Company news

DRI Healthcare Trust news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences

March 26, 2024

DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2023 Results

February 28, 2024

DRI Healthcare Trust to Host Fourth Quarter and Full Year 2023 Earnings Call and Webcast on February 29, 2024

February 8, 2024

DRI Healthcare Trust Announces the Expansion of its Royalty Entitlement on the US Net Sales of Omidria®, Updates Deployment and CAGR Guidance

February 1, 2024

DRI Healthcare Trust Declares Special Distributions

December 20, 2023

DRI Healthcare Trust Reports Third Quarter 2023 Results

November 13, 2023

DRI Healthcare Trust Announces Upsized US$500 Million Credit Facilities

October 31, 2023

DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 14, 2023

October 24, 2023

DRI Healthcare Trust Closes C$104 Million Bought Deal Public Offering Including Full Exercise of Over-Allotment Option

September 20, 2023

DRI Healthcare Trust Reports Second Quarter 2023 Results

August 14, 2023

DRI Healthcare Trust Announces Acquisition of a Second Royalty Interest in the Worldwide Sales of ORSERDU® (elacestrant) and Updates Long-Term Guidance

August 14, 2023

DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 15, 2023

July 25, 2023

DRI Healthcare Trust Completes C$98 Million Bought Deal Public Offering of Units

July 19, 2023

DRI Healthcare Trust Announces Acquisition of an Additional Royalty Interest in the Worldwide Sales of VONJO® (pacritinib)

July 7, 2023

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Net Sales of Orserdu(TM) (elacestrant) and Reiterates Long-Term Cash Receipts Outlook

June 30, 2023

DRI Healthcare Trust Announces US$54.8 Million Debt Repayment from CTI BioPharma Corp.

June 26, 2023

DRI Healthcare Trust Reports First Quarter 2023 Results

May 11, 2023

DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 12, 2023

April 27, 2023

DRI Healthcare Trust Announces Sale of its TZIELD(TM) Royalty Interest to Sanofi for US$210 Million and Announces a US$20 Million Special Cash Distribution to Unitholders

April 27, 2023

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of TZIELD(TM) (teplizumab-mzwv) and Updates Long-Term Cash Receipts Outlook

March 8, 2023

DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2022 Results

March 1, 2023

DRI Healthcare Trust to Host Fourth Quarter and Full Year 2022 Earnings Call and Webcast on March 2, 2023

February 16, 2023

DRI Healthcare Trust Announces US$95 million Private Placement of Preferred Securities and Increased Deployment Target

February 8, 2023

DRI Healthcare Trust Declares Unit Distribution and Provides Update on Normal Course Issuer Bid

December 21, 2022

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of Xenpozyme® (olipudase alfa) for the Treatment of Acid Sphingomyelinase Deficiency

November 28, 2022

DRI Healthcare Trust Reports Third Quarter 2022 Results

November 7, 2022

DRI Healthcare Trust Announces Appointment of Poonam Puri to Board of Trustees

November 7, 2022

DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 8, 2022

October 25, 2022

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of Omidria® for Intracameral Use During Cataract Surgery or Intraocular Lens Replacement

October 3, 2022

DRI Healthcare Trust Provides Update on Natpara Royalty

October 3, 2022

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in Zejula®, Currently Approved for the Treatment of Ovarian Cancer with Additional Indications Under Development

September 12, 2022

DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 4, 2022

July 21, 2022

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of pegcetacoplan Including Empaveli® /Aspaveli® for the Treatment of Paroxysmal Nocturnal Hemoglobinuria

July 21, 2022

DRI Healthcare Trust Reports First Quarter 2022 Results

May 10, 2022

DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 11, 2022

April 27, 2022

DRI Healthcare Trust Announces Upsized Credit Facility

April 20, 2022

DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2021 Results

March 7, 2022

DRI Healthcare Trust Comments on FDA Approval of VONJOTM (pacritinib)

March 1, 2022

DRI Healthcare Trust to Host Fourth Quarter Earnings Call and Webcast on March 8, 2022

February 22, 2022

DRI Healthcare Trust Comments on Extension of Review Period for pacritinib

November 30, 2021

DRI Healthcare Trust Reports Third Quarter 2021 Results and Announces Increase to Quarterly Distribution

November 8, 2021

DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 9, 2021

October 25, 2021

DRI Healthcare Trust Announces US$200 Million Credit Facility

October 22, 2021

DRI Healthcare Trust Announces Acceptance by TSX of Normal Course Issuer Bid

September 30, 2021

DRI Healthcare Trust Announces Acquisition of Royalty on Oracea®

September 30, 2021

DRI Healthcare Trust to Host Conference Call to Discuss Transaction Announcement

August 25, 2021

CTI BioPharma and DRI Healthcare Trust Announce up to $135 Million Debt and Royalty Transaction

August 25, 2021

DRI Healthcare Trust Reports Second Quarter 2021 Results

August 5, 2021

DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 6, 2021

July 26, 2021

DRI Healthcare Trust Reports First Quarter 2021 Results

May 10, 2021

← Newer news releases · Older news releases →

Calls

Decks

The 5 newest of 55 decks. Every deck is listed under its year.